Key result
Pretreatment with captopril significantly ameliorated LPS-induced sickness behaviors, including reducing immobility time in the forced swimming test (p<0.001), and attenuated serum IL-6 levels.
Why the study?
Does captopril improve LPS-induced sickness behaviors and reduce IL-6 levels in rats?
Does captopril improve LPS-induced sickness behaviors and reduce IL-6 levels in rats?
p-value: p=<0.001
Captopril ameliorates LPS-induced sickness behaviors and reduces inflammatory marker IL-6 in a rat model, suggesting potential neuro-immune modulating effects.
Supports captopril investigation in preclinical LPS models; leaves open translation to human inflammatory conditions.
of captopril restored the IL-6 level in comparison with the sham group. Results confirmed that pretreatment with captopril ameliorated LPS-caused sickness behaviors and attenuated IL-6 as an inflammatory marker in the rats.
No takes yet. Share an insight, caveat, or question.
Abareshi et al. (2019) studied Lipopolysaccharide-induced sickness behaviors (n=50). Captopril vs. Sham (LPS + saline) and Control (saline) was evaluated on Immobility time in forced swimming test (p=<0.001). Pretreatment with captopril significantly ameliorated LPS-induced sickness behaviors, including reducing immobility time in the forced swimming test (p<0.001), and attenuated serum IL-6 levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: